Advertisement

Virologica Sinica

, 26:324 | Cite as

Evaluation of efficacy of stabilizers on the thermostability of live attenuated thermo-adapted Peste des petits ruminants vaccines

  • Thachamvally Riyesh
  • Vinayagamurthy Balamurugan
  • Arnab Sen
  • Veerakyathappa Bhanuprakash
  • Gnanavel Venkatesan
  • Vinita Yadav
  • Raj Kumar Singh
Article

Abstract

In this study, thermo-adapted (Ta) PPR vaccines were assessed for their stability at 25, 37, 40, 42 and 45°C in lyophilized form using two extrinsic stabilizers {lactalbumin hydrolysate-sucrose (LS) and stabilizer E} and in reconstituted form with the diluents (1 mol/L MgSO4 or 0.85% NaCl). The lyophilized vaccines showed an expiry period of 24–26 days at 25°C, 7–8 days at 37°C and 3–4 days at 40°C. LS stabilizer was superior at 42°C with a shelf-life of 44 h, whereas in stabilizer E, a 40 h shelf-life with a comparable half-life was observed. At 45°C, the half-life in stabilizer E was better than LS and lasted for 1 day. Furthermore, the reconstituted vaccine maintained the titre for 48 h both at 4°C and 25°C and for 24–30 h at 37°C. As both the stabilizers performed equally well with regard to shelf-life and half-life, the present study suggests LS as stabilizer as a choice for lyophilization with 0.85% NaCl diluent, because it has better performance at higher temperature. These Ta vaccines can be used as alternatives to existing vaccines for the control of the disease in tropical countries as they are effective in avoiding vaccination failure due to the breakdown in cold-chain maintenance, as this vaccine is considerably more stable at ambient temperatures.

Key words

PPR Thermo-adapted Vaccines Stabilizers Diluents Thermo-stability 

References

  1. 1.
    Adebayo A A, Sim-Brandenburg J W, Emmel H, et al. 1998. Stability of 17D yellow fever virus vaccine using different stabilizers. Biologicals, 26(4): 309–316.PubMedCrossRefGoogle Scholar
  2. 2.
    Amorij J P, Huckriede A, Wilschut J, et al. 2008. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm Res, 25(6): 1256–1273.PubMedCrossRefGoogle Scholar
  3. 3.
    Balamurugan V, Sen A, Venkatesan G, et al. 2010. Sequence and Phylogenetic Analyses of the Structural Genes of Virulent Isolates and Vaccine Strains of Peste Des Petits Ruminants Virus from India. Trans Emerg Dis, 57: 352–364.CrossRefGoogle Scholar
  4. 4.
    Balamurugan V, Sen A, Venkatesan G, et al. 2010. Isolation and Identification of virulent peste des petits ruminants viruses from PPR outbreaks in India. Trop Anim Health Prod, 42: 1043–1046.PubMedCrossRefGoogle Scholar
  5. 5.
    Boyd RJ, Hanson R P. 1958. Survival of Newcastle disease virus in nature. Avian Dis, 2: 82–93.CrossRefGoogle Scholar
  6. 6.
    Diallo A, Taylor W P, Lefevre P C, et al. 1989. Attenuation of a strain of rinderpest virus: potential homologous live vaccine. Rev Elev Med Vet Pays Trop, 42(3): 311–319.PubMedGoogle Scholar
  7. 7.
    Diallo A, Minet C, Le Goff C, et al. 2007. The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine, 25(30): 5591–5597.PubMedCrossRefGoogle Scholar
  8. 8.
    Lancz G J. 1976. Effect of pH on the kinetics of herpes simplex virus inactivation at 36 degrees. Virology, 75(2): 488–491.PubMedCrossRefGoogle Scholar
  9. 9.
    Mariner J C, House J A, Sollod A E, et al. 1990. Comparison of the effect of various chemical stabilizers and lyophilization cycles on the thermostability of Vero cell-adapted rinderpest vaccine. Vet Microbiol, 21(3): 195–209.PubMedCrossRefGoogle Scholar
  10. 10.
    Rajak K K, Sreenivasa B P, Hosamani M, et al. 2005. Experimental studies on immunosuppressive effects of peste des petits ruminants (PPR) virus in goats. Comp Immunol Microbiol Inf Dis, 28: 287–296.CrossRefGoogle Scholar
  11. 11.
    Raut A A, Singh R K, Malik M, et al. 2001. Development of a thermoresistant tissue culture rinderpest vaccine virus. Acta Virol, 45: 235–241.PubMedGoogle Scholar
  12. 12.
    Reed L J, Muench H A. 1938. A Simple method of estimating fifty percent end points. Am J Hyg, 27: 493–497.Google Scholar
  13. 13.
    Report of the FAO Expert Consultation on Rinderpest Diagnosis. Vaccine Production and Quality Control, Food and Agriculture Organization of the United Nations, Rome, 1985.Google Scholar
  14. 14.
    Samuel D, Megson B, Ftrang M, et al. 2000. A microtiterplate method for isolation and typing of poliovirus using a blue cell ELISA. Virol Methods, 90: 125–133.CrossRefGoogle Scholar
  15. 15.
    Saravanan P, Balamurugan V, Sen A, et al. 2010. Long term immune response of goats to a Vero cell adapted live attenuated homologous PPR vaccine. Indian Vet J, 87: 1–3.Google Scholar
  16. 16.
    Sarkar J, Sreenivasa B P, Singh R P, et al. 2003. Comparative efficacy of various chemical stabilizers on the thermo stability of a live-attenuated peste des petits ruminants (PPR) vaccine. Vaccine, 21(32): 4728–4735.PubMedCrossRefGoogle Scholar
  17. 17.
    Shiomi H, Urasawa T, Urasawa S. 2003. Heat stability of the lyophilized Sabin polio vaccine. Jpn J Infect Dis, 56(2): 70–72.PubMedGoogle Scholar
  18. 18.
    Singh R K, Balamurugan V, Bhanuprakash V, et al. 2009. Possible control and eradication of peste des petits ruminants from India: technical aspects. Vet Ital, 45(3): 449–462.PubMedGoogle Scholar
  19. 19.
    Singh R P, De U K, Pandey K D. 2010. Virological and antigenic characterization of two Peste des Petits Ruminants (PPR) vaccine viruses of Indian origin. Comp Immunol Microbiol Infect Dis, 33(4): 343–353.PubMedCrossRefGoogle Scholar
  20. 20.
    Singh R P, Saravanan P, Sreenivasa B P, et al. 2004. Prevalence and distribution of peste des petits ruminants virus infection in small ruminants in India. Rev Sci Tech Off Int Epiz, 23: 807–819.Google Scholar
  21. 21.
    Singh R P, Sreenivasa B P, Dhar P, et al. 2004. Development of monoclonal antibody based competitive-ELISA for detection and titration of antibodies to peste des petits ruminants virus. Vet Microbiol, 98: 3–15.PubMedCrossRefGoogle Scholar
  22. 22.
    Singh RP. 2002. Production and characterization of monoclonal antibodies to peste des petits ruminants (PPR) virus. PhD Thesis, Submitted to Deemed University, IVRI, Izatnagar, India.Google Scholar
  23. 23.
    Sokhey J, Gupta CK, Sharma B, et al. 1988. Stability of oral polio vaccine at different temperatures. Vaccine, 6(1): 12–13.PubMedCrossRefGoogle Scholar
  24. 24.
    Velayudhan B T, Lopes V C, Noll S L, et al. 2003. Avian pneumovirus and its survival in poultry litter. Avian Dis, 47(3): 764–768.PubMedCrossRefGoogle Scholar
  25. 25.
    Worrall E E, Litamoi J K, Seck B M, et al. 2000. Xerovac: an ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines. Vaccine, 19(7–8): 834–839.PubMedCrossRefGoogle Scholar
  26. 26.
    Zhai S, Hansen R K, Taylor R, et al. 2004. Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization. Biotechnol Prog, 20(4): 1113–1120.PubMedCrossRefGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Thachamvally Riyesh
    • 1
    • 2
  • Vinayagamurthy Balamurugan
    • 1
    • 3
  • Arnab Sen
    • 1
  • Veerakyathappa Bhanuprakash
    • 1
  • Gnanavel Venkatesan
    • 1
  • Vinita Yadav
    • 1
  • Raj Kumar Singh
    • 1
    • 4
  1. 1.Division of VirologyIndian Veterinary Research InstituteNainital DistrictIndia
  2. 2.Veterinary Type cultures CentreNational Research Centre on EquinesHisarIndia
  3. 3.Project Directorate on Animal Disease Monitoring And Surveillance (PD-ADMAS)HebbalIndia
  4. 4.National Research Centre on EquinesHisarIndia

Personalised recommendations